Artisan Partners
TARS icon

Artisan Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Artisan Partners’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Sell
284,899
-22,408
-7% -$1.43M 0.03% 266
2026
Q1 		$21.6M Sell
307,307
-129,269
-30% -$9.03M 0.03% 277
2025
Q4 		$35.7M Sell
436,576
-121,750
-22% -$9.09M 0.05% 257
2025
Q3 		$33.2M Buy
558,326
+19,023
+4% +$937K 0.05% 250
2025
Q2 		$21.8M Sell
539,303
-63,911
-11% -$2.88M 0.03% 287
2025
Q1 		$31M Sell
603,214
-88,085
-13% -$4.35M 0.05% 255
2024
Q4 		$38.3M Sell
691,299
-17,719
-2% -$805K 0.06% 262
2024
Q3 		$23.3M Buy
709,018
+81,440
+13% +$2.29M 0.03% 278
2024
Q2 		$17.1M Buy
627,578
+148
+0% +$4.98K 0.03% 288
2024
Q1 		$22.8M Buy
627,430
+237,419
+61% +$6.98M 0.03% 265
2023
Q4 		$7.9M Sell
390,011
-9,166
-2% -$153K 0.01% 297
2023
Q3 		$7.09M Buy
+399,177
New +$7.06M 0.01% 289

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Artisan Partners's TARS Position: Q2 2026 in Review

Artisan Partners reduced its Tarsus Pharmaceuticals (TARS) stake by 7.3% in Q2 2026, selling an estimated $1.43M and leaving 284,899 shares worth $17.9M. The position accounts for 0.03% of the portfolio, ranked #266.

Artisan Partners first reported a position in TARS in Q3 2023 and has held it in 12 quarters since. The position peaked at $38.3M in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Artisan Partners held 284,899 shares of Tarsus Pharmaceuticals worth $17.9M as of Q2 2026.
  • Artisan Partners sold 22,408 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.43M.
  • Tarsus Pharmaceuticals made up 0.03% of Artisan Partners's portfolio in Q2 2026, its #266 holding.
  • Artisan Partners first reported a position in Tarsus Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Artisan Partners's Tarsus Pharmaceuticals position peaked at $38.3M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.